Why Did Aptevo Therapeutics Stock Jump 25% Today?

Aptevo Therapeutics Inc APVO shares are trading higher Thursday after the company reported 2021 financial results. 

Aptevo said royalty revenue totaled $12.3 million in 2021, up from royalties of $4.3 million in 2020. The company reported a net loss of $28.5 million or $6.07 per share, which was worse than the net loss of $17.8 million or $5.23 per share during the prior year.

Aptevo said it had cash and cash equivalents of $46.3 million at the end of 2021.

Aptevo is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics for the treatment of different forms of cancer.

See Also: Why Ampio Pharmaceuticals Stock Is Rising Today

APVO 52-Week Range: $4.40 - $32.57

The stock was up 25.2% at $6.56 at publication time.

Photo: Belova59 from Pixabay.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!